Fortress Biotech FBIO
NASDAQ FBIO
$2.05 -0.02 (-1.21%)
As of: Oct 2, 2026 · 12:44 PM EDT

Fortress Biotech (FBIO) Liabilities from Discontinued Operations (2017)

Updated

Fortress Biotech's Liabilities from Discontinued Operations came in at $29.28 million for Q4 2017.

Analysis

Fortress Biotech (FBIO) Liabilities from Discontinued Operations (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Fortress Biotech 71.29 Mn -323.33 Mn 12.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 29.28 Mn
API Access

Fortress Biotech Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=FBIO&period=max&api_key=YOUR_API_KEY